What is Greentree?
Greentree operates as a comprehensive pharmacy services provider, distinguishing itself through a vertically integrated model that encompasses skilled nursing support, assisted living coordination, and advanced infusion and compounding capabilities. By maintaining internal control over personnel training and leveraging state-of-the-art technology, the company ensures a high standard of care for complex patient populations. Its market position is defined by its ability to provide 24-hour support and personalized pharmaceutical interventions, serving as a critical partner for group homes and long-term care facilities that require specialized, reliable medication management.
How much funding has Greentree raised?
Greentree has raised a total of $75K across 1 funding round:
Debt
$75K
Debt (2021): $75K with participation from PPP
Key Investors in Greentree
PPP
Public-Private Partnership
What's next for Greentree?
With the recent influx of capital, Greentree is poised to accelerate its operational footprint and enhance its technological infrastructure. The strategic focus will likely shift toward optimizing its compounding and infusion service lines to meet the rising demand for specialized pharmacy care in institutional settings. By scaling its dedicated care teams and refining its proprietary service delivery model, the company aims to solidify its competitive advantage in the healthcare services sector. Future growth will be driven by the expansion of its client base in skilled nursing and correctional facilities, where the demand for high-acuity pharmacy support remains robust.
See full Greentree company page
